1 Pharm D Intern Nazareth College of Pharmacy, Othera, Kerala, India.
2 Pharm D Intern Nazareth College of Pharmacy, Othera, Kerala, India.
3 Clinical Pharmacist Believers Church Medical College Hospital, Kerala, India.
4 Clinical Pharmacist Believers Church Medical College Hospital, Kerala, India.
5 Head of Department of Pharmacology, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.
World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 626-631
Article DOI: 10.30574/wjbphs.2025.21.1.0107
Received on 17 December 2024; revised on 25 January 2025; accepted on 28 January 2025
Escitalopram is a Selective Serotonin Receptor Inhibitor (SSRI) prescribed for the management of anxiety, major depressive disorders, agitation, and dementia. Hyponatremia is a familiar side effect of SSRIs; however, there are only a few pieces of literature that give evidence of escitalopram-induced hyponatremia and hyponatremic encephalopathy. SSRIs are also known to cause rare neurological side effects, such as extrapyramidal symptoms like tremulousness, Parkinsonism, which often go unlisted. SSRIs may cause visual hallucinations.
Selective Serotonin Receptor Inhibitors; Hyponatremia; Hyponatremic encephalopathy; Parkinsonism; Escitalopram; Visual hallucinations; Tremulousness
Preview Article PDF
CHRISTEENA MARY VIJI, MERIN.V. JOLLY, HARIKRISHNAN S, RINKU ELSA REJI and JACOB JESURUN R S. Unveiling the adverse effects of escitalopram: A case series analysis. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 626-631. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.1.0107.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0